Publications by authors named "Jeremy Braybrooke"

Claim this Profile
T
The Mistletoe and Breast Cancer (MAB) Study: A UK Mixed-Phase, Pilot, Placebo-Controlled, Double-Blind, Randomised Controlled Trial.
Lorna J Duncan, Susan Bryant, Gene Feder, Maria Gresham, Poppy Gibson, Jeremy P Braybrooke

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.
Jean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, Karen Pinilla Alba, Alimu Dayimu, Jeremy P Braybrooke

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Jean E Abraham, Karen Pinilla, Alimu Dayimu, Louise Grybowicz, Nikolaos Demiris, Jeremy P Braybrooke

Nature· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply.
Jeremy Braybrooke, Rosie Bradley, Richard Gray, Robert Hills,

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer.
Amit Bahl, William Wilson, Jessica Ball, Emily Renninson, Sidharth Dubey, Jeremy Braybrooke

Breast· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, Gordon J S Rustin, Syed A Sohaib, Jeremy Braybrooke

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Nicholas C Turner, Belinda Kingston, Lucy S Kilburn, Sarah Kernaghan, Andrew M Wardley, Jeremy P Braybrooke

Lancet Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Jeremy P Braybrooke

NPJ Breast Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Zuzana Kos, Elvire Roblin, Rim S Kim, Stefan Michiels, Brandon D Gallas, Jeremy P Braybrooke

NPJ Breast Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
David O Hall, Clare E Hooper, Julie Searle, Michael Darby, Paul White, Jeremy P Braybrooke

Nucl Med Commun· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mutational frequency of BRAF and KRAS in low-grade serous testicular neoplasms-a case series.
Paidamwoyo Gwiti, Ildikó Vereczkey, David Cundell, Shazia Aslam, Tim Clench, Jeremy Braybrooke

Histopathology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor

N Engl J Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the 21-gene assay on adjuvant treatment decisions in oestrogen receptor-positive early breast cancer: a prospective study.
Anna Kuchel, Tim Robinson, Charles Comins, Mike Shere, Mohini Varughese, Jeremy P Braybrooke

Br J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.
Amelia O Clive, Clare E Hooper, Anthony J Edey, Anna J Morley, Natalie Zahan-Evans, Jeremy P Braybrooke

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
Jack R Broadfoot, Hilary A Archer, Elizabeth Coulthard, Auke P A Appelman, Judit Sutak, Jeremy P Braybrooke

Pract Neurol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and oncological management of malignant mesothelioma.
Anna C Bibby, Lara Gibbs, Jeremy P Braybrooke

Br J Hosp Med (Lond)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How has early testicular cancer affected your life? A study of sexual function in men attending active surveillance for stage one testicular cancer.
Sue Brand, Hilary Williams, Jeremy Braybrooke

Eur J Oncol Nurs· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.
Stephen Rd Johnston, Lucy S Kilburn, Paul Ellis, David Dodwell, David Cameron, Jeremy P Braybrooke

Lancet Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of uncommon chemotherapy-induced emergencies.
Carys Morgan, Tania Tillett, Jeremy Braybrooke, Thankamma Ajithkumar

Lancet Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coherent ultrasonic Doppler tomography.
Chun Sing Louis Tsui, Hai-Dong Liang, Michael Halliwell, Mike Shere, Jeremy P Braybrooke

Ultrasound Med Biol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Return of the postcode lottery.
John Graham, Sam Guglani, Sean Elyan, Stephen Falk, Jeremy Braybrooke

BMJ· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended survival in women with brain metastases from HER2 overexpressing breast cancer.
David N Church, Ramayana Modgil, Sam Guglani, Amit Bahl, Kirsten Hopkins, Jeremy P Braybrooke

Am J Clin Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
Srinivasan Madhusudan, Sethupathi R Muthuramalingam, Jeremy P Braybrooke, Susan Wilner, Kulwinder Kaur

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.
Jeremy P Braybrooke, Andrew Slade, Gael Deplanque, Richard Harrop, Srinivasan Madhusudan

Clin Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.
Srinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, Jeremy P Braybrooke, Susan Wilner

Clin Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis